Pharma BD Deal Intelligence

Bayer AG / Algeta ASA

2002 · Acquisition/Merger · $2.9B · Complete

Announcement Sentiment

63

Positive

Outcome Score

45

Mixed — partial payoff, real shortfalls.

Bayer acquired Algeta for ~$2.9B for radiotherapeutic Xofigo for cancer.

Key facts

Announced Nov 25, 2002
Closed Mar 12, 2014
Deal value $2.9B
Deal type Acquisition/Merger
Therapeutic area Oncology
Key assets Xofigo

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals